Press releases

5
Dec 2013
21:30 E.S.T.

Cellectis announces an acceleration of its strategic refocusing on therapeutics and agrobusiness

Read more
26
Sep 2013
20:30 E.S.T.

Cellectis announces first-half 2013 financial results

Read more
23
Sep 2013
20:30 E.S.T.

Cellectis bioresearch launches Compact TALEN™ the next generation of TAL effector nucleases

Read more
8
Jul 2013
20:30 E.S.T.

Scéil™: a new offering for the general public to turn adult cells into stem cells and store them

Read more
4
Jul 2013
20:30 E.S.T.

Cellectis Group announces groundbreaking in vivo proof of concept testing of their flagship UCART19 product for curative therapy of leukemia

Read more
26
Jun 2013
20:30 E.S.T.

Cellectis has successfully engineered the genome of photosynthetic algae with a view to biofuel production

Read more
18
Jun 2013
20:30 E.S.T.

Cellectis SA Combined General Shareholders’ Meeting of June 14, 2013

Read more
6
Jun 2013
20:30 E.S.T.

Cellectis plant sciences CEO Luc Mathis joins Board of Directors of the French Association for Plant Biotechnology (AFBV)

Read more
28
May 2013
20:30 E.S.T.

TAL-effector nuclease: The USPTO issues a third patent licensed to Cellectis

Read more
21
May 2013
20:30 E.S.T.

Compact TALEN™: the next generation of TAL effector nucleases – The Scientific journal Nature Communications publishes an innovative study on ultra precise Compact TALEN™ mini DNA cutters

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US